ScopeGreat Ormond Street Hospital for Children NHS Foundation Trust
99 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Haematology Department, (Haematology and Blood Transfusion, SIHMDS), Level 1 Camelia Botnar Laboratories, Great Ormond Street Hospital
London WC1N 3JH , United Kingdom
London WC1N 3JH , United Kingdom
Accreditation
Active
UKAS
8623
gosh.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8623
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Great Ormond Street Hospital for Children NHS Foundation Trust
London
Great Ormond Street Hospital for Children NHS Foundation Trust
London
Great Ormond Street Hospital for Children NHS Foundation Trust
Camelia Botnar Laboratories
Great Ormond Street Hospital for Children NHS Foundation Trust
37 Queen Square
Great Ormond Street Hospital for Children NHS Foundation Trust
London
Great Ormond Street Hospital for Children NHS Foundation Trust
Camelia Botnar Laboratories
Great Ormond Street Hospital for Children NHS Foundation Trust
Camelia Botnar Laboratories
Test Capabilities (99)
| Standard Reference | Description | Category |
|---|---|---|
| Alpha 2 Antiplasmin | Alpha 2-Antiplasmin | Clinical Chemistry |
| Antithrombin Antigen | Antithrombin-Antigen | Clinical Chemistry |
| Biochemistry examination activities for the purpose of clinical diagnosis | Biochemistry examination activities for the purpose of clinical diagnosis: Metabolic biochemistry | Clinical Chemistry |
| Coagulation Screen: APTT and mixing studies | Coagulation screen: | Photometric end-point clot | Clinical Chemistry |
| Glucose-6-Phosphate (G6PD) quantitation | Glucose-6-Phosphate (G6PD) quantitation | Clinical Chemistry |
| Quantitation of Methotrexate | Quantitation of Methotrexate | Clinical Chemistry |
| ABO/D blood groups | ABO/D blood groups | Hematology |
| Activated Protein C Resistance (APCR) | Activated Protein C Resistance (APCr) | Hematology |
| AntiThrombin Activity | Antithrombin activity | Hematology |
| Antibody Screening | Antibody Screening | Hematology |
| Basophils | Basophils | Hematology |
| Binding Assay (vW:CBA) | Binding Assay (vW:CBA) | ELISA read on | Hematology |
| Blood transfusion examinations | Blood transfusion examinations | Hematology |
| Concentration (MCHC) | Concentration (MCHC) | Hematology |
| Direct Antiglobulin TEST (DAT) | Direct Antiglobulin Test (DAT): Detection of antibodies adsorbed on the red cell membrane | Hematology |
| Eosinophils | Eosinophils | Hematology |
| Erythrocyte Sedimentation Rate (ESR) | Erythrocyte Sedimentation Rate (ESR) | Hematology |
| Factor XIII | Factor XIII | Hematology |
| Factors II, V, VII, VIII, IX, X, XI, XII | Factors II, V, VII, VIII, IX, X, XI, XII | Hematology |
| Full Bone marrow / blood characterization | Full Bone marrow / blood characterization | Hematology |
| Full blood counts and automated differential: Haemoglobin (Hb) | Full blood counts and automated differential: Haemoglobin (Hb) | Hematology |
| Haematocrit | Haematocrit | Hematology |
| Haematology examinations for the purposes of clinical diagnosis | Haematology examinations for the purposes of clinical diagnosis | Hematology |
| Heparin Anti Xa activity | Heparin Anti Xa activity | Hematology |
| Inhibitor Assays - FVIII, FIX | Inhibitor Assays - FVIII, FIX | Hematology |
| Lupus Anticoagulant Screen by | Lupus Anticoagulant Screen by | Hematology |
| Lymphocytes | Lymphocytes | Hematology |
| Mean Cell Haemoglobin | Mean Cell Haemoglobin | Hematology |
| Mean Cell Haemoglobin (MCH) | Mean Cell Haemoglobin (MCH) | Hematology |
| Mean Cell Volume (MCV) | Mean Cell Volume (MCV) | Hematology |
| Monocytes | Monocytes | Hematology |
| NRBC | NRBC | Hematology |
| Neutrophils | Neutrophils | Hematology |
| Platelet Count | Platelet Count | Hematology |
| Platelet function (PFA) | Platelet function (PFA) | Hematology |
| Protein C Activity | Protein C activity | Hematology |
| Red Blood Count (RBC) | Red Blood count (RBC) | Hematology |
| Red Cell Distribution Width (RDW) | Red Cell Distribution Width (RDW) | Hematology |
| Reticulocytes | Reticulocytes | Hematology |
| Sickle Solubility test for presence of sickle haemoglobin (HbS) | Sickle solubility test for presence of sickle haemoglobin (HbS) | Hematology |
| Staining and examination of peripheral Blood Film: Detection of normal and abnormal morphologies and white blood cell differential | Staining and examination of peripheral Blood Film: Detection of normal and abnormal morphologies and white blood cell differential | Hematology |
| White Blood Cell Count (WBC) | White Blood Cell Count (WBC) | Hematology |
| White Cell Count, Red Cell Count | White Cell Count, Red Cell Count | Hematology |
| White Cell Count, Red Cell Count and White Cell Differential | White Cell Count, Red Cell Count and White Cell Differential | Hematology |
| B Cells | CD79a | B-Cells | CD79a | Histopathology / Cytology |
| Staining and examination of bone marrow films: in order to identify or exclude Morphological and Cytological abnormalities for the purpose of diagnosis | Staining and examination of bone marrow films: in order to identify or exclude Morphological and Cytological abnormalities for the purpose of diagnosis | Histopathology / Cytology |
| ABO Isohaemagglutinins (IgG/IgM) | ABO Isohaemagglutinins (IgG/IgM) | Immunology / Serology |
| Anti-A IgM immunoglobulin | Anti-A IgM immunoglobulin | Immunology / Serology |
| Anti-B IgM immunoglobulin | Anti-B IgM immunoglobulin | Immunology / Serology |
| Antibody screening and identification using cells containing the following antigens: D,C,E,c,e,Cw,K,k,Kpa,Kpb,Fya,Fyb, Jka,Jkb,Lea,Leb,P1,M,N,S,s, Lua | Antibody screening and identification using cells containing the following antigens: D,C,E,c,e,Cw,K,k,Kpa,Kpb,Fya,Fyb, Jka,Jkb,Lea,Leb,P1,M,N,S,s, Lua | Immunology / Serology |
| Blood grouping by antigen screening: ABO/D blood groups | Blood grouping by antigen screening: • ABO/D blood groups • Antibody screening | Immunology / Serology |
| Compatibility Testing | Compatibility Testing: | Manual Biovue crossmatching BTR-S-031 | Immunology / Serology |
| Free Protein S Antigen | Free Protein S Antigen | Immunology / Serology |
| IgM heterophile antibodies | IgM heterophile antibodies | Immunology / Serology |
| Immunophenotyping examinations for the purposes of clinical diagnosis | Immunophenotyping examinations for the purposes of clinical diagnosis | Immunology / Serology |
| MPO | MPO | Immunology / Serology |
| Malarial Parasite Antigen for pLDH (plasmodium Lactate Dehydrogenase). Detects | Malarial Parasite Antigen for pLDH (plasmodium Lactate Dehydrogenase). Detects | Immunology / Serology |
| Red cell phenotyping for the following antigens: C, c, D, E, e | Red cell phenotyping for the following antigens: C,E,c,e,Cw,K, Isohaemagglutinins | Immunology / Serology |
| Screen | screen: | • Human recombinant | Immunology / Serology |
| (CAR T) | (CAR T) | Molecular Diagnostics / PCR |
| 0.0001% (within maximum range of 1 – 5 logs) | 0.0001% (within maximum range of 1 – 5 logs) | Molecular Diagnostics / PCR |
| Chimerism genotyping | Chimerism genotyping | Molecular Diagnostics / PCR |
| Kymriah Chimeric Antigen Receptor | Kymriah Chimeric Antigen Receptor | Molecular Diagnostics / PCR |
| Leiden and Prothrombin Variant | Leiden and Prothrombin Variant | Molecular Diagnostics / PCR |
| Molecular testing examinations for the purposes of clinical diagnosis | Molecular testing examinations for the purposes of clinical diagnosis | Molecular Diagnostics / PCR |
| Mutation detection for Factor V | Mutation detection for Factor V | Molecular Diagnostics / PCR |
| Quantification of T cell receptor diversity | Quantification of T cell receptor diversity | Molecular Diagnostics / PCR |
| Thymic T-cell recovery | Thymic T-cell recovery | Molecular Diagnostics / PCR |
| B-Cell Precursor Acute | B-Cell Precursor Acute | Other |
| B-cell maturation phenotyping | B-cell maturation phenotyping | Other |
| CD66abce expression | CD66abce expression | Other |
| CyCD3 | CyCD3 | Other |
| DRVVT | dRVVT | Other |
| Disease (MRD) in Myeloid and Lymphoid Leukaemia - detected levels of a leukaemia associated immunophenotype | Disease (MRD) in Myeloid and Lymphoid Leukaemia - detected levels of a leukaemia associated immunophenotype | Other |
| Erythroid phenotyping | Erythroid phenotyping | Other |
| Extended Myeloid immunophenotyping | Extended Myeloid immunophenotyping | Other |
| FACTOR VIII | Factor VIII | Other |
| Glandular fever by detection of IM | Glandular fever by detection of IM | Other |
| Glucose-6-Phosphate (G6PD) | Glucose-6-Phosphate (G6PD) | Other |
| Intracellular Marker Expression | Intracellular Marker Expression | Other |
| Lymphoblastic Leukaemia (BCP- ALL) Flow MRD quantification using the CYT-BCP B-Cell Precursor | Lymphoblastic Leukaemia (BCP- ALL) Flow MRD quantification using the CYT-BCP B-Cell Precursor | Other |
| Lymphoid phenotyping | Lymphoid phenotyping | Other |
| Lymphoma phenotyping | Lymphoma phenotyping | Other |
| Myelodysplastic / Myeloproliferative phenotyping: CD19, CD2, CD34, CD10, CD13, CD45, CD20,CD16, CD7, CD4, CD5, CD117, CD33, HLADR, sCD3, CD8, CD79b, CD38, CD86, CD44, NG2, CD24,CD22, CD41a, CD42b, CD61, CD11b, CD15, CD14, CD64, CD71, GlyA, CD133, CD56 Others as indicated: Kappa, Lambda, CD1a, SmIg, TCRalpha/beta, TCR gamma/delta, CD123, CD21, PD1 | Myelodysplastic / Myeloproliferative phenotyping: CD19, CD2, CD34, CD10, CD13, CD45, CD20,CD16, CD7, CD4, CD5, CD117, CD33, HLADR, sCD3, CD8, CD79b, CD38, CD86, CD44, NG2, CD24,CD22, CD41a, CD42b, CD61, CD11b, CD15, CD14, CD64, CD71, GlyA, CD133, CD56 Others as indicated: Kappa, Lambda, CD1a, SmIg, TCRalpha/beta, TCR gamma/delta, CD123, CD21, PD1 | Other |
| NG2 expression | NG2 expression | Other |
| Neuroblastoma Panel – by detecting non haematopoietic population that meet NBL phenotype criteria | Neuroblastoma Panel – by detecting non haematopoietic population that meet NBL phenotype criteria | Other |
| Nocturnal Haemoglobinuria (PNH) clone | Nocturnal Haemoglobinuria (PNH) clone | Other |
| Panel for patients enrolled on the All2gether trial | Panel for patients enrolled on the All2gether trial | Other |
| Plasmodium +/-Falciparum (HRP 2 ) | Plasmodium +/-Falciparum (HRP 2 ) | Other |
| Platelet Glycoproteins | Platelet glycoproteins | Other |
| Quantification of Minimal Residual | Quantification of Minimal Residual | Other |
| Quantification of Paroxysmal | Quantification of Paroxysmal | Other |
| Quantification of surface expression of platelet glycoproteins GpIb, GpIIb/IIIa and GpIIIa | Quantification of surface expression of platelet glycoproteins GpIb, GpIIb/IIIa and GpIIIa | Other |
| Range of Measurement: 10 – | Range of Measurement: 10 – | Other |
| Red cell membrane defects by calculating the EMA ratio | Red cell membrane defects by calculating the EMA ratio | Other |
| Semiquantitative detection of Total | Semiquantitative detection of Total | Other |
| T-cell phenotyping | T-cell phenotyping | Other |
| TDT | TDT | Other |
| Plasminogen | Plasminogen | Spectroscopy (XRF, ICP, AAS) |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.